Abbisko Cayman Limited (HK:2256)
:2256
Comparison Results
Abbisko Cayman Limited
HK$13.02
HK$9.01B
135.64
103.53%
3 Buy
0 Hold
0 Sell
Strong Buy
Alphamab Oncology
HK$9.39
HK$9.15B
-76.25
58.35%
1 Buy
0 Hold
0 Sell
Moderate Buy
Ascletis Pharma, Inc.
HK$17.95
HK$19.05B
-9.33
272.41%
2 Buy
1 Hold
0 Sell
Moderate Buy
HBM Holdings Ltd.
HK$12.08
HK$12.61B
5.89
120.25%
1 Buy
0 Hold
0 Sell
Moderate Buy
CStone Pharmaceuticals
HK$5.34
HK$14.64B
-15.44
335.93%
2 Buy
0 Hold
0 Sell
Moderate Buy
Shandong Boan Biotechnology Company., Limited. Class H
HK$7.15
HK$4.45B
558.59
-12.59%
―
Performance Comparison
HK:2256
Abbisko Cayman Limited
13.25
6.05
84.03%
HK:9966
Alphamab Oncology
9.39
2.74
41.20%
HK:1672
Ascletis Pharma, Inc.
17.95
12.18
211.09%
HK:2142
HBM Holdings Ltd.
14.25
6.48
83.40%
HK:2616
CStone Pharmaceuticals
10.07
7.40
277.15%
HK:6955
Shandong Boan Biotechnology Company., Limited. Class H
7.15
-1.13
-13.65%